Logo-apb
Adv Pharm Bull. 2023;13(1): 24-35. doi: 10.34172/apb.2023.003
PMID: 36721812        PMCID: PMC9871280

Review Article

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy

Somayyeh Ghareghomi 1 ORCID, Vahideh Atabaki 2 ORCID, Naseh Abdollahzadeh 3, Shahin Ahmadian 1 * ORCID, Salar Hafez Ghoran 4,5 * ORCID

Cited by CrossRef: 2


1- Liu Y, Ding W, Wang J, Ao X, Xue J. Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. Front Oncol. 2023;13 [Crossref]
2- Hussain Y, Khan H, Alam W, Aschner M, Aschner A, Alsharif K, Saso L, Curcio M. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxidative Medicine and Cellular Longevity. 2022;2022:1 [Crossref]